Antibiotic-coated nail for fusion of infected charcot ankles. Academic Article uri icon

Overview

abstract

  • BACKGROUND: Treating infected ankles in patients with neuropathy is difficult, and complications are frequently encountered. Eradication of infection and effective arthrodesis are required for a successful outcome. The purpose of this study was to evaluate the outcomes of patients with Charcot neuropathy whose infected ankles were treated with a retrograde, antibiotic-coated, locked intramedullary nail. METHODS: We analyzed 5 patients with infected neuroarthropathy of the ankle joint. Three patients had failed treatment with the circular external fixator for infected neuroarthropathy of the ankle. The other 2 were treated primarily by this technique. All patients were treated with surgical nonunion repair, arthrodesis, and insertion of an antibiotic-coated, locked intramedullary nail. The average age was 59 years (range, 46 to 82 years). The average follow up period was 18 months (range, 12-24 months). RESULTS: The average time taken for radiological healing was 4.1 months (range, 4-4.5 months). In all patients, bony union was achieved and infection was eradicated. There were no cases of hardware failure. CONCLUSION: Antibiotic-coated nails were used to treat infected ankle nonunions and infected distal tibial fractures in Charcot patients with successful bony union, fusion, and eradication of infection. LEVEL OF EVIDENCE: Level IV, therapeutic study.

publication date

  • January 1, 2013

Research

keywords

  • Ankle Joint
  • Anti-Bacterial Agents
  • Arthrodesis
  • Arthropathy, Neurogenic
  • Bone Nails
  • Coated Materials, Biocompatible
  • Osteomyelitis

Identity

Scopus Document Identifier

  • 84874816798

Digital Object Identifier (DOI)

  • 10.1177/1071100712460209

PubMed ID

  • 23386765

Additional Document Info

volume

  • 34

issue

  • 1